Coherus Oncology, Inc. CHRS
0.37 USD -0.02 (-4.47%)
Regular-session close
0.37 0.00 +0.59%
After hours · Nov 20, 6:09 PM ET
0.3628 Day range 0.4084
0.3628 52-week range 2.62
- YTD
- -73.96%
- 1 year
- -66.38%
CHRS revenue history
Revenue is income from the company’s ordinary business activities.
42,172,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 42,172,000 | 15,783,000 | 59.81% |
| FY 2024 | 2024-12-31 | 26,389,000 | -230,855,000 | -89.74% |
| FY 2023 | 2023-12-31 | 257,244,000 | 46,202,000 | 21.89% |
| FY 2022 | 2022-12-31 | 211,042,000 | -115,509,000 | -35.37% |
| FY 2021 | 2021-12-31 | 326,551,000 | -149,273,000 | -31.37% |
| FY 2020 | 2020-12-31 | 475,824,000 | 119,753,000 | 33.63% |
| FY 2019 | 2019-12-31 | 356,071,000 | 356,071,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | -1,556,000 | -100.00% |
| FY 2017 | 2017-12-31 | 1,556,000 | -188,550,000 | -99.18% |
| FY 2016 | 2016-12-31 | 190,106,000 | 160,065,000 | 532.82% |
| FY 2015 | 2015-12-31 | 30,041,000 | -1,065,000 | -3.42% |
| FY 2014 | 2014-12-31 | 31,106,000 | 28,355,000 | 1030.72% |
| FY 2013 | 2013-12-31 | 2,751,000 | 852,000 | 44.87% |
| FY 2012 | 2012-12-31 | 1,899,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:00:49.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
